Czapska, M., Babkiewicz, K., Pabis, S., & Skórzyńska-Dziduszko, K. (2018). Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus. Journal of Education, Health and Sport, 8(12), 335–351. Retrieved from https://apcz.umk.pl/JEHS/article/view/6378